Kahaku Emoto

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

Peter C. Taylor, Edward Keystone, Désirée van der Heijde et al. · New England Journal of Medicine · 2017 · 895 citations · Full text

Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study

Yoshiya Tanaka, Kahaku Emoto, Zhihong Cai et al. · The Journal of Rheumatology · 2016 · 120 citations · Full text

Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan

Hiroyuki Nagase, Mitsuru Adachi, Kazuto Matsunaga et al. · Allergology International · 2019 · 113 citations · Full text

Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study

Peter C. Taylor, E C Keystone, D. van der Heijde et al. · Data Archiving and Networked Services (DANS) · 2015 · 21 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +10